NSPR · InspireMD, Inc.
$0.85
+0.01 (+1.26%)
At close · Sep 4
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has concluded that there is substantial doubt about our ability to continue as a going concern, and our condensed financial statements for the quarter ended June 30, 2026 includes an explanatory paragraph as to our ability to continue as a going concern, which could prevent us from obtaining new financing on reasonable terms or at all.”View the 10-Q filed Aug 14, 2026
Market Cap
$39.66M
Shares
46.49M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$8.98M
+28.1%
FY2025
Net Income
-$48.79M
-52.4%
FY2025
Gross Margin
29.5%
+8pp
FY2025
Operating Margin
-552.56%
-74.6pp
FY2025
Diluted EPS
-$0.76
0%
FY2025
Operating Cash Flow
-$35.1M
-60.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $10.84M | $8.98M | $7.01M | $6.21M | $5.17M | $4.5M | $2.49M | $3.72M | $3.6M | $2.76M | $1.89M | $2.31M | $2.82M | $4.87M | $6M | $4.95M | $3.41M | |
| $8.88M | $6.33M | $5.5M | $4.4M | $4.05M | $3.74M | $2.4M | $2.97M | $2.61M | $2.18M | $1.79M | $2.61M | $2.03M | $2.28M | $3.01M | $2.7M | $2.29M | |
| $1.96M | $2.65M | $1.51M | $1.81M | $1.12M | $754K | $83K | $756K | $995K | $585K | $102K | -$296K | $784K | $2.59M | $2.99M | $2.25M | $1.12M | |
| — | 29.5% | 21.49% | 29.12% | 21.6% | 16.77% | 3.34% | 20.32% | 27.63% | 21.19% | 5.39% | -12.81% | 27.82% | 53.15% | 49.85% | 45.52% | 32.83% | |
| $16.17M | $15M | $13.63M | $7.98M | $7.81M | $5.16M | $2.23M | $2.95M | $1.54M | $1.28M | $1.29M | $3.64M | $8.74M | $4.16M | $2.47M | $1.34M | $1.33M | |
| $20.03M | $16.55M | $6.07M | $3.87M | $3.66M | $2.91M | $2.1M | $2.4M | $2.24M | $2.36M | $1.46M | $3.18M | $6.61M | $3.62M | $1.97M | $1.24M | $1.04M | |
| $19.32M | $20.71M | $15.31M | $11.1M | $8.36M | $7.41M | $6.13M | $5.22M | $4.83M | $5.18M | $5M | $6.39M | $9.13M | $8.97M | $12.28M | $2.9M | $1.47M | |
| — | — | — | — | — | — | — | — | — | — | — | — | $148K | $132K | — | — | — | |
| — | $476M | $280M | $232M | $188M | $161K | $151K | $158K | $139K | $153K | $142K | $152K | $263K | $208K | $89K | $91K | $89K | |
| — | — | — | — | — | — | — | — | — | — | — | $406K | — | — | — | — | — | |
| $55.52M | $52.26M | $35.01M | $22.95M | $19.83M | $15.47M | $10.46M | $10.57M | $8.61M | $8.82M | $7.75M | $14.19M | $24.48M | $17.66M | $16.72M | $5.47M | $3.84M | |
| -$53.56M | -$49.61M | -$33.5M | -$21.14M | -$18.71M | -$14.72M | -$10.38M | -$9.82M | -$7.61M | -$8.23M | -$7.65M | -$14.49M | -$23.7M | -$15.07M | -$13.73M | -$3.22M | -$2.72M | |
| — | -552.56% | -478% | -340.74% | -361.88% | -327.39% | -417.71% | -263.8% | -211.36% | -298.15% | -403.8% | -627.06% | -840.95% | -309.32% | -228.66% | -65.04% | -79.65% | |
| — | $426.39M | $246.5M | $210.86M | $169.29M | -$14.56M | -$10.23M | -$9.66M | -$7.47M | -$8.08M | -$7.51M | -$14.33M | -$23.44M | -$14.87M | -$13.64M | -$3.13M | -$2.63M | |
| — | — | — | — | — | — | — | — | — | $119K | $721K | $1.04M | $1.41M | $4.27M | $730K | $105K | $221K | |
| — | — | — | — | — | — | — | — | — | — | — | — | $2000 | $28K | $36K | $1000 | $1000 | |
| $1.14M | $891K | $1.56M | $1.29M | $250K | -$157K | -$160K | -$200K | -$371K | — | — | — | -$1.39M | -$14.18M | -$934K | -$154K | $40K | |
| — | -$48.72M | -$31.95M | -$19.85M | -$18.46M | -$14.87M | -$10.54M | -$10.02M | -$7.24M | -$8.41M | -$8.46M | -$15.58M | -$25.08M | -$29.25M | -$14.66M | -$3.37M | -$2.68M | |
| — | $63K | $59K | $65K | $28K | $45K | $4000 | $24K | — | $27K | $1000 | $4000 | $12K | $8000 | $2000 | $47K | $47K | |
| -$52.48M | -$48.79M | -$32.01M | -$19.92M | -$18.49M | -$14.92M | -$10.54M | -$10.04M | -$7.24M | -$8.44M | -$8.46M | -$15.59M | -$25.1M | -$29.26M | -$14.67M | -$3.42M | -$2.72M | |
| — | -543.33% | -456.63% | -320.97% | -357.59% | -331.88% | -424.31% | -269.82% | -201.06% | -305.61% | -446.73% | -674.68% | -890.53% | -600.41% | -244.25% | -69.1% | -79.86% | |
| — | — | — | — | — | — | — | — | -$7.7M | -$13.03M | -$8.46M | — | — | — | — | — | — | |
| USD/shares | -$1.05 | -$0.76 | -$0.76 | -$0.82 | -$2.35 | -$2.03 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | -$1.05 | -$0.76 | -$0.76 | -$0.82 | -$2.35 | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 64.33M | 41.93M | 24.27M | 7.87M | 7.35M | 1.51M | 139.33K | 30.77K | 24.83K | 2715.4667 | 18.6K | 235.96K | 1.4M | — | — | — |
| shares | — | 64.33M | 41.93M | 24.27M | 7.87M | 7.35M | 1.51M | 139.33K | 30.77K | 24.83K | 2715.4667 | 18.6K | 235.96K | 1.4M | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2013–FY2014: $42K in buybacks.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.21×
EV/EBIT
—
Peer median 17.44×
P/E (TTM)
—
Peer median 23.38×
Peer medians compare against the 68 similar-size Medical Devices companies (of 145 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Other Countries | $4,061,000 | $3,421,000 | $3,376,000 | $2,954,000 | $2,566,000 | $1,181,000 |
| United States | $1,417,000 | $32,000 | — | — | — | — |
| Germany | $1,233,000 | $926,000 | $896,000 | $866,000 | $948,000 | $708,000 |
| Italy | $1,232,000 | $1,223,000 | $1,195,000 | $970,000 | $981,000 | $596,000 |
| Poland | $1,036,000 | $694,000 | — | — | — | — |
| Russia | — | $713,000 | $738,000 | $381,000 | — | — |
By Product & Service (USD)
| Component | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| CGuard EPS | $6,205,000 | $5,123,000 | $4,309,000 | $2,764,000 |
| MGuard Prime EPS | — | $48,000 | $186,000 | -$279,000 |
Key facts
CIK
1433607
CUSIP
45779A846
13F (30d)
24 filings
24 filers
Visit website
Investor relations